-IANS Debunking the government's claim that the number of poor in India has come down, a top adviser has claimed that around 70 % of the country's 1.2 billion population is poor, and stressed the need for a multi-dimensional assessment of poverty. "The government claim that poverty has come down is not valid... there is a need for a multi-dimensional assessment of poverty as around 70% of the population is poor," National Advisory...
More »SEARCH RESULT
‘I lost my husband....others shouldn't suffer a similar fate'-Neha Alawadhi
Kin of many slain whistleblowers were present at Anna's fast Coming down heavily on the government, social activist Anna Hazare on Sunday said nothing was being done to protect the whistleblowers who play a crucial role in fighting corruption. Families of several whistleblowers who lost their lives in the fight against corruption turned up at Mr. Hazare's day-long fast at Jantar Mantar here. Team Anna said at least 15 people who tried to...
More »Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government-M Suchitra
Says respond else face action Annoyed by the non-submission of reports regarding illegal clinical trials of breast cancer drug, the National Human Rights Commission (NHRC) has issued notices to the Union health ministry and the Andhra Pradesh government. It has asked the Centre and the state government to respond within six weeks or face action. The commission had in June last year sent notices to the Union health secretary, secretary of the...
More »In whose welfare?-Gaurav Choudhury
One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »